INDIVIDUALIZATION OF TREATMENT OF HYPERLIPOPROTEINEMIC DISORDERS = INDIVIDUALISATION DU TRAITEMENT DES TROUBLES HYPERLIPOPROTEINEMIQUESAZARNOFF DL.1974; MED. CLIN. N. AMER.; U.S.A.; DA. 1974; VOL. 58; NO 5; PP. 1129-1135; BIBL. 24REF.Article

DIPHENYLHYDANTOIN POTENCY AND PLASMA PROTEIN BINDING. = PUISSANCE DE LA DIPHENYLHYDANTOINE ET FIXATION AUX PROTEINES DU PLASMASHOEMAN DW; AZARNOFF DL.1975; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1975; VOL. 195; NO 1; PP. 84-86; BIBL. 18 REF.Article

DRUGS AND DRUG METABOLITES AS ENVIRONMENTAL CONTAMINANTS: CHLOROPHENOXYISOBUTYRATE AND SALICYLIC ACID IN SEWAGE WATER EFFLUENT.HIGNITE C; AZARNOFF DL.1977; LIFE SCI.; G.B.; DA. 1977; VOL. 20; NO 2; PP. 337-341; BIBL. 9 REF.Article

IDENTIFICATION OF METHOTREXATE AND FOLIC ACID ANALOGS BY MASS SPECTROMETRY.HIGNITE CE; AZARNOFF DL.1978; BIOMED. MASS SPECTROM.; G.B.; DA. 1978; VOL. 5; NO 2; PP. 161-163; BIBL. 9 REF.Article

DRUG PROTEIN BINDING AND THE NEPHROTIC SYNDROMEGUGLER R; AZARNOFF DL.1976; CLIN. PHARMACOKINET.; NETHERL.; DA. 1976; VOL. 1; NO 1; PP. 25-35; BIBL. 1 P. 1/2Article

THERAPEUTIC IMPLICATIONS OF BIOAVAILABILITYAZARNOFF DL; HUFFMAN DH.1976; ANNU. REV. PHARMACOL. TOXICOL.; U.S.A.; DA. 1976; VOL. 16; PP. 53-66; BIBL. 2 P. 1/2Article

CLINICAL PHARMACOKINETICS OF METHOTREXATE.SHEN DD; AZARNOFF DL.1978; CLIN. PHARMACOKINET.; NETHERL.; DA. 1978; VOL. 3; NO 1; PP. 1-13; BIBL. 3 P.Article

HIGH-PRESSURE LIQUID CHROMATOGRAPHIC ASSAY OF THEOPHYLLINE IN BIOLOGICAL FLUIDSMANION CV; SHOEMAN DW; AZARNOFF DL et al.1974; J. CHROMATOGR.; NETHERL.; DA. 1974; VOL. 101; NO 1; PP. 169-174; BIBL. 6 REF.Article

METABOLIC RESPONSES TO PLASMA CONCENTRATIONS OF THEOPHYLLINECATHCART RAKE WF; KYNER JL; AZARNOFF DL et al.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 26; NO 1; PP. 89-95; BIBL. 40 REF.Article

DIPHENYLHYDANTOIN: CORRELATION BETWEEN PROTEIN BINDING AND ALBUMIN CONCENTRATION = CORRELATION ENTRE LA LIAISON DIPHENYLHYDANTOINE-PROTEINES ET LA CONCENTRATION DU PLASMA EN ALBUMINEGUGLER R; AZARNOFF DL; SHOEMAN DW et al.1975; KLIN. WSCHR.; DTSCH.; DA. 1975; VOL. 53; NO 9; PP. 445-446; ABS. ALLEM.; BIBL. 13REF.Article

EFFECT OF PORTACAVAL SHUNT ON THE DISPOSITION OF DRUGS WITH AND WITHOUT FIRST-PASS EFFECT. = EFFET D'UN SHUNT PORTOCAVE SUR LE SORT DES MEDICAMENTS AVEC ET SANS EFFET DE PREMIER PASSAGEGUGLER R; LAIN P; AZARNOFF DL et al.1975; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1975; VOL. 195; NO 3; PP. 416-423; BIBL. 19 REF.Article

SEPARATION AND QUANTITATIVE ANALYSIS OF FUROSEMIDE AND 4-CHLORO-5-SULFAMOYLANTHRANILIC ACID (CSA) BY HIGH PRESSURE LIQUID CHROMATOGRAPHY = SEPARATION ET DOSAGE DU FUROSEMIDE ET DE L'ACIDE CHLORO-4 SULFAMOYL-5 ANTHRANILIQUE (ACS) PAR CHROMATOGRAPHIE EN PHASE LIQUIDE SOUS P ELEVEEMACDOUGALL ML; SHOEMAN DW; AZARNOFF DL et al.1975; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1975; VOL. 10; NO 2; PP. 285-292; BIBL. 13REF.Serial Issue

DISPOSITION KINETICS OF DISOPYRAMIDE IN PATIENTS WITH RENAL INSUFFICIENCYSHEN DD; CUNNINGHAM JL; AZARNOFF DL et al.1980; BIOPHARM. DRUG DISPOS.; GBR; DA. 1980; VOL. 1; NO 3; PP. 133-140; BIBL. 25 REF.Article

INTERSUBJECT VARIATION IN ABSORPTION OF DIGOXIN IN NORMAL VOLUNTEERS = VARIATION ENTRE LES SUJETS DANS L'ABSORPTION DE LA DIGOXINE CHEZ DES VOLONTAIRES NORMAUXHUFFMAN DH; MANION CV; AZARNOFF DL et al.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 3; PP. 433-437; BIBL. 13REF.Article

INHIBITION OF AMPHETAMINE TOLERANCE AND METABOLISM BY PROPRANOLOL = INHIBITION DE LA TOLERANCE A L'AMPHETAMINE ET DE SON METABOLISME PAR LE PROPRANOLOLSHOEMAN DW; SIRTORI CR; AZARNOFF DL et al.1974; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1974; VOL. 191; NO 1; PP. 68-71; BIBL. 13 REF.Article

ABSORPTION IN DIGOXIN FROM DIFFERENT ORAL PREPARATIONS IN NORMAL SUBJECTS DURING STEADY STATEHUFFMAN DH; MANION CV; AZARNOFF DL et al.1974; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1974; VOL. 16; NO 2; PP. 310-317; BIBL. 24REF.Article

BIOAVAILABILITY STUDIES ON PARA-AMINOSALICYLIC ACID AND ITS VARIOUS SALTS IN MAN. I. ABSORPTION FROM SOLUTION AND SUSPENSIONSUK HAN WAN; PENTIKAINEN P; AZARNOFF DL et al.1974; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1974; VOL. 2; NO 1; PP. 1-12; BIBL. 19REF.Article

THEOPHYLLINE BIOAVAILABILITY. A COMPARISON OF THE ORAL ABSORPTION OF A THEOPHYLLINE ELIXIR AND TWO COMBINATION THEOPHYLLINE TABLETS TO INTRAVENOUS AMINOPHYLLINE.FIXLEY M; SHEN DD; AZARNOFF DL et al.1977; AMER. REV. RESP. DIS.; U.S.A.; DA. 1977; VOL. 115; NO 6; PP. 955-962; BIBL. 21 REF.Article

PLACENTAL TRANSFER AND FETAL URINARY EXCRETION OF GENTAMICIN DURING CONSTANT RATE MATERNAL INFUSION = TRANSFERT PLACENTAIRE ET EXCRETION URINAIRE PAR LE FOETUS DE LA GENTAMICINE EN COURS DE PERFUSION MATERNELLE A VITESSE CONSTANTEKAUFFMAN RE; MORRIS JA; AZARNOFF DL et al.1975; PEDIATR. RES.; U.S.A.; DA. 1975; VOL. 9; NO 2; PP. 104-107; BIBL. 21 REF.Article

EFFECT OF IN VIVO ELEVATION OF FREE FATTY ACIDS ON PROTEIN BINDING OF DRUGS = EFFET DE L'ACCROISSEMENT IN VIVO DES ACIDES GRAS LIBRES SUR LA FIXATION DES MEDICAMENTS AUX PROTEINESGUGLER R; SHOEMAN DW; AZARNOFF DL et al.1974; PHARMACOLOGY; SWITZ.; DA. 1974; VOL. 12; NO 3; PP. 160-165; BIBL. 15REF.Article

BIOAVAILABILITY OF AMINOSALICYLIC ACID AND ITS VARIOUS SALTS IN HUMAN. IV. COMPARISON OF FOUR BRANDS OF THE SODIUM SALT = LA BIODISPONIBILITE DE L'ACIDE AMINOSALICYLIQUE ET DE SES DIFFERENTS SELS CHEZ L'HOMME. IV. COMPARAISON DE 4 MARQUES DE SELS DE SODIUMPENTIKAINEN PJ; SUK HAN WAN; AZARNOFF DL et al.1974; J. PHARM. SCI.; U.S.A.; DA. 1974; VOL. 63; NO 9; PP. 1431-1434; BIBL. 15REF.Article

DISSOCIATION OF THE METABOLIC AND CARDIOVASCULAR EFFECTS OF THE BETA-ADRENERGIC BLOCKER PRACTOLOL = DISSOCIATION DES EFFETS METABOLIQUES ET CARDIOVASCULAIRES D'UN AGENT BLOQUANT BETA -ADRENERGIQUE: LE PRACTOLOLSIRTORI CR; AZARNOFF DL; SHOEMAN DW et al.1972; PHARMACOL. RES. COMMUNIC.; G.B.; DA. 1972; VOL. 4; NO 2; PP. 123-133; BIBL. 1 P.Serial Issue

METABOLIC RESPONSES TO L-DOPA ADMINISTRATION IN PATIENTS WITH PARKINSONISMSIRTORI CR; BOLME P; AZARNOFF DL et al.1972; NEW ENGL. J. MED.; U.S.A.; DA. 1972; VOL. 287; NO 15; PP. 729-733; BIBL. 31 REF.Serial Issue

DI-(2-ETHYLHEXYL) PHTHALATE: AN INDUSTRIAL PLASTICIZER INDUCES HYPOLIPIDEMIA AND ENHANCES HEPATIC CATALASE AND CARNITINE ACETYLTRANSFERASE ACTIVITIES IN RATS AND MICE.REDDY JK; MOODY DE; AZARNOFF DL et al.1976; LIFE SCI.; G.B.; DA. 1976; VOL. 18; NO 9; PP. 941-945; BIBL. 18 REF.Article

PLASMA LEVELS AND EXCRETION OF ESTROGENS IN URINE IN CHRONIC LIVER DISEASE.PENTIKAEINEN PJ; PENTIKAEINEN LA; AZARNOFF DL et al.1975; GASTROENTEROLOGY; U.S.A.; DA. 1975; VOL. 69; NO 1; PP. 20-27; BIBL. 25 REF.Article